One person per pathway
A named contact at GP network level, RTC pathway and QbTech — to help design the handoff protocol and confirm what visibility is appropriate at each stage.
I navigated it privately because I had the resources to do so. Most people in this cohort don't. OTOS makes the Right to Choose route visible, receipted and traceable from first contact — without adding clinical burden to a single GP.
"I've been briefed on OTOS Continuity™ — a non-clinical communications layer that helps make the Right to Choose referral pathway visible and receipted for adults with co-occurring ADHD and addiction. I understand it does not add to GP clinical workload, does not access any clinical system, and is designed to work alongside existing RTC and QbTech pathways. I'd like to explore the GP/RTC role in the scoping conversation."
Edit as you see fit. Two minutes to send. No commitment beyond the note.
Send this note →Right to Choose was the pathway that finally got me assessed. But I only found it because I had the resources, the language and the fight left to navigate it. I paid £900 for a private psychiatric assessment to confirm what I already knew, so I could present the evidence to a GP who could then refer me via RTC.
That is an expensive, inaccessible, fragmented route to a straightforward referral. For the adults in the ADHD + addiction cohort, that navigation is close to impossible — and so they never get there.
OTOS makes the RTC pathway visible from the moment someone first touches services. It doesn't change how GPs make referrals. It makes it more likely that the referral gets made — and that it's visible as receipted when it does.
OTOS does not add to the GP referral process. It sits alongside it — making the thread visible from the moment referral is made, without requiring a single additional clinical step.
A named contact at GP network level, RTC pathway and QbTech — to help design the handoff protocol and confirm what visibility is appropriate at each stage.
When a GP makes an RTC referral for someone in the pre-pilot cohort, OTOS logs it as a receipted thread step. No extra clinical action required — just visibility that it happened.
Map the RTC pathway, agree what OTOS makes visible and what stays private, and design the lightest-possible touch for GP participation.
One note. One conversation. That is all it takes to start.